- Home
- VNRX vs IPSC Comparison
VNRX vs IPSC Comparison
Compare VNRX & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNRX
- IPSC
- Stock Information
- Founded
- VNRX N/A
- IPSC 2019
- Country
- VNRX United States
- IPSC United States
- Employees
- VNRX N/A
- IPSC 165
- Industry
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- IPSC Medicinal Chemicals and Botanical Products
- Sector
- VNRX Health Care
- IPSC Health Care
- Exchange
- VNRX Nasdaq
- IPSC Nasdaq
- Market Cap
- VNRX 52.4M
- IPSC 49.6M
- IPO Year
- VNRX N/A
- IPSC 2021
- Fundamental
- Price
- VNRX $0.80
- IPSC $0.58
- Analyst Decision
- VNRX Strong Buy
- IPSC Strong Buy
- Analyst Count
- VNRX 5
- IPSC 5
- Target Price
- VNRX $3.88
- IPSC $3.33
- AVG Volume (30 Days)
- VNRX 307.1K
- IPSC 868.9K
- Earning Date
- VNRX 08-13-2025
- IPSC 08-07-2025
- Dividend Yield
- VNRX N/A
- IPSC N/A
- EPS Growth
- VNRX N/A
- IPSC N/A
- EPS
- VNRX N/A
- IPSC N/A
- Revenue
- VNRX $1,308,361.00
- IPSC $114,898,000.00
- Revenue This Year
- VNRX $563.72
- IPSC $1,064.82
- Revenue Next Year
- VNRX $160.43
- IPSC N/A
- P/E Ratio
- VNRX N/A
- IPSC N/A
- Revenue Growth
- VNRX 64.16
- IPSC 8286.72
- 52 Week Low
- VNRX $0.40
- IPSC $0.34
- 52 Week High
- VNRX $0.94
- IPSC $3.29
- Technical
- Relative Strength Index (RSI)
- VNRX 75.61
- IPSC 52.16
- Support Level
- VNRX $0.40
- IPSC $0.58
- Resistance Level
- VNRX $0.75
- IPSC $0.66
- Average True Range (ATR)
- VNRX 0.08
- IPSC 0.04
- MACD
- VNRX 0.02
- IPSC -0.00
- Stochastic Oscillator
- VNRX 69.33
- IPSC 41.52
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.